General anaesthetics and the developing brain: An overview

Anaesthesia

Volumn 69, Issue 9, 2014, Pages 1009-1022

  Sinner, B ^a   Becke, K ^b   Engelhard, K ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Hallerwiese Clinic   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; SHORT ACTING DRUG;

BRAIN DEVELOPMENT; CLINICAL STUDY; COGNITION; GENERAL ANESTHESIA; HUMAN; IMMATURITY; LOCAL ANESTHESIA; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROTOXICITY; NONHUMAN; REGIONAL ANESTHESIA; RETROSPECTIVE STUDY; REVIEW;

ANESTHESIA, CONDUCTION; ANESTHESIA, GENERAL; ANESTHETICS, GENERAL; ANIMALS; BRAIN; CHILD; CHILD, PRESCHOOL; COGNITION; HUMANS; INFANT; INFANT, NEWBORN; NERVE DEGENERATION; NEUROTOXICITY SYNDROMES;

EID: 84905976533     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12637     Document Type: Review

References (121)

1. Cowan WM,. The development of the brain. Scientific American 1979; 241: 113-33.
2. LaMantia AS, Rakic P,. Axon overproduction and elimination in the anterior commissure of the developing rhesus monkey. Journal of Comparative Neurology 1994; 340: 328-36. (Pubitemid 24042208)
3. Bourgeois JP,. Synaptogenesis, heterochrony and epigenesis in the mammalian neocortex. Acta Paediatrica Suppl 1997; 422: 27-33. (Pubitemid 27345458)
4. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW,. Mapping cortical change across the human life span. Nature Neuroscience 2003; 6: 309-15. (Pubitemid 36278290)
5. Nguyen L, Rigo JM, Rocher V, et al. Neurotransmitters as early signals for central nervous system development. Cell and Tissue Research 2001; 305: 187-202. (Pubitemid 32684574)
6. Herlenius E, Lagercrantz H,. Development of neurotransmitter systems during critical periods. Experimental Neurology 2004; 190 (Suppl 1): S8-21. (Pubitemid 39451785)
7. Dobbing J, Sands J,. Head circumference, biparietal diameter and brain growth in fetal and postnatal life. Early Human Development 1978; 2: 81-7. (Pubitemid 8332677)
8. Petit TL, LeBoutillier JC, Gregorio A, Libstug H,. The pattern of dendritic development in the cerebral cortex of the rat. Brain Research 1988; 469: 209-19.
9. Zhou ZW, Shu Y, Li M, et al. The glutaminergic, GABAergic, dopaminergic but not cholinergic neurons are susceptible to anaesthesia-induced cell death in the rat developing brain. Neuroscience 2011; 174: 64-70.
10. Slikker W Jr, Zou X, Hotchkiss CE, et al. Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicological Science 2007; 98: 145-58. (Pubitemid 47073827)
11. Brambrink AM, Evers AS, Avidan MS, et al. Ketamine-induced neuroapoptosis in the fetal and neonatal rhesus macaque brain. Anesthesiology 2012; 116: 372-84.
12. Hayashi H, Dikkes P, Soriano SG,. Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Pediatric Anesthesia 2002; 12: 770-4. (Pubitemid 36051344)
13. Johnson SA, Young C, Olney JW,. Isoflurane-induced neuroapoptosis in the developing brain of nonhypoglycemic mice. Journal of Neurosurgical Anesthesiology 2008; 20: 21-8. (Pubitemid 351628035)
14. Stratmann G, Sall JW, May LD, Loepke AW, Lee MT,. Beyond anesthetic properties: the effects of isoflurane on brain cell death, neurogenesis, and long-term neurocognitive function. Anesthesia and Analgesia 2010; 110: 431-7.
15. Slikker W Jr, Paule MG, Wright LK, Patterson TA, Wang C,. Systems biology approaches for toxicology. Journal of Applied Toxicology 2007; 27: 201-17. (Pubitemid 46663415)
16. Scallet AC, Schmued LC, Slikker W Jr, et al. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicological Science 2004; 81: 364-70. (Pubitemid 39377966)
17. Zhu C, Gao J, Karlsson N, et al. Isoflurane anesthesia induced persistent, progressive memory impairment, caused a loss of neural stem cells, and reduced neurogenesis in young, but not adult, rodents. Journal of Cerebral Blood Flow and Metabolism 2010; 30: 1017-30.
18. Stratmann G, May LD, Sall JW, et al. Effect of hypercarbia and isoflurane on brain cell death and neurocognitive dysfunction in 7-day-old rats. Anesthesiology 2009; 110: 849-61.
19. Zou X, Patterson TA, Divine RL, et al. Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. International Journal of Developmental Neuroscience 2009; 27: 727-31.
20. Sinner B, Friedrich O, Zink W, Zausig Y, Graf BM,. The toxic effects of s(+)-ketamine on differentiating neurons in vitro as a consequence of suppressed neuronal Ca2+ oscillations. Anesthesia and Analgesia 2011; 113: 1161-9.
21. Vutskits L, Gascon E, Tassonyi E, Kiss JZ,. Clinically relevant concentrations of propofol but not midazolam alter in vitro dendritic development of isolated gamma-aminobutyric acid-positive interneurons. Anesthesiology 2005; 102: 970-6. (Pubitemid 40586538)
22. Young C, Jevtovic-Todorovic V, Qin YQ, et al. Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. British Journal of Pharmacology 2005; 146: 189-97. (Pubitemid 43079958)
23. Viberg H, Ponten E, Eriksson P, Gordh T, Fredriksson A,. Neonatal ketamine exposure results in changes in biochemical substrates of neuronal growth and synaptogenesis, and alters adult behavior irreversibly. Toxicology 2008; 249: 153-9.
24. Soriano SG, Liu Q, Li J, et al. Ketamine activates cell cycle signaling and apoptosis in the neonatal rat brain. Anesthesiology 2010; 112: 1155-63.
25. Yon JH, Daniel-Johnson J, Carter LB, Jevtovic-Todorovic V,. Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience 2005; 135: 815-27.
26. Kuida K, Zheng TS, Na S, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368-72. (Pubitemid 26408520)
27. Cattano D, Young C, Straiko MM, Olney JW,. Subanesthetic doses of propofol induce neuroapoptosis in the infant mouse brain. Anestheisa and Analgesia 2008; 106: 1712-4.
28. Zhang X, Xue Z, Sun A,. Subclinical concentration of sevoflurane potentiates neuronal apoptosis in the developing C57BL/6 mouse brain. Neuroscience Letters 2008; 447: 109-14.
29. Jetovic-Todorovic V, Hartmann RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persisting learning deficits. Journal of Neuroscience 2003; 23: 876-82. (Pubitemid 36206178)
30. Briner A, Nikonenko I, De Roo M, Dayer A, Muller D, Vutskits L,. Developmental Stage-dependent persistent impact of propofol anesthesia on dendritic spines in the rat medial prefrontal cortex. Anesthesiology 2011; 115: 282-93.
31. Edwards DA, Shah HP, Cao W, Gravenstein N, Seubert CN, Martynyuk AE,. Bumetanide alleviates epileptogenic and neurotoxic effects of sevoflurane in neonatal rat brain. Anesthesiology 2010; 112: 567-75.
32. Head BP, Patel HH, Niesman IR, Drummond JC, Roth DM, Patel PM,. Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system. Anesthesiology 2009; 110: 813-25.
33. Lemkuil BP, Head BP, Pearn ML, Patel HH, Drummond JC, Patel PM,. Isoflurane neurotoxicity is mediated by p75NTR-RhoA activation and actin depolymerization. Anesthesiology 2011; 114: 49-57.
34. Brambrink AM, Back SA, Riddle A, et al. Isoflurane-induced apoptosis of oligodendrocytes in the neonatal primate brain. Annals of Neurology 2012; 72: 525-35.
35. Creeley C, Dikranian K, Dissen G, Martin L, Olney J, Brambrink A,. Propofol-induced apoptosis of neurones and oligodendrocytes in fetal and neonatal rhesus macaque brain. British Journal of Anaesthesia 2013; 110 (Suppl 1): i29-38.
36. Pearn ML, Hu Y, Niesman IR, et al. Propofol neurotoxicity is mediated by p75 neurotrophin receptor activation. Anesthesiology 2012; 116: 352-61.
37. Briner A, De Roo M, Dayer A, Muller D, Habre W, Vutskits L,. Volatile anesthetics rapidly increase dendritic spine density in the rat medial prefrontal cortex during synaptogenesis. Anesthesiology 2010; 112: 546-56.
38. Vutskits L, Gascon E, Potter G, Tassonyi E, Kiss JZ,. Low concentrations of ketamine initiate dendritic atrophy of differentiated GABAergic neurons in culture. Toxicology 2007; 234: 216-26. (Pubitemid 46635958)
39. Sinner B, Friedrich O, Zausig Y, Bein T, Graf BM,. Toxic effects of midazolam on differentiating neurons in vitro as a consequence of suppressed neuronal Ca2+-oscillations. Toxicology 2011; 290: 96-101.
40. Mintz CD, Barrett KM, Smith SC, Benson DL, Harrison NL,. Anesthetics interfere with axon guidance in developing mouse neocortical neurons in vitro via a gamma-aminobutyric acid type A receptor mechanism. Anesthesiology 2013; 118: 825-33.
41. Vutskits L, Gascon E, Tassonyi E, Kiss JZ,. Effect of ketamine on dendritic arbor development and survival of immature GABAergic neurons in vitro. Toxicological Science 2006; 91: 540-9. (Pubitemid 43827306)
42. De Roo M, Klauser P, Briner A, et al. Anesthetics rapidly promote synaptogenesis during a critical period of brain development. PLoS One 2009; 4: e7043.
43. Popic J, Pesic V, Milanovic D, et al. Propofol-induced changes in neurotrophic signaling in the developing nervous system in vivo. PlosOne 2012; 7: 34396.
44. Sanchez V, Feinstein SD, Lunardi N, et al. General anesthesia causes long-term impairment of mitochondrial morphogenesis and synaptic transmission in developing rat brain. Anesthesiology 2011; 115: 992-1002.
45. Boscolo A, Starr JA, Sanchez V, et al. The abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: the importance of free oxygen radicals and mitochondrial integrity. Neurobiology of Disease 2012; 45: 1031-41.
46. Nagele P, Tallchief D, Blood J, Sharma A, Kharasch ED,. Nitrous oxide anesthesia and plasma homocysteine in adolescents. Anesthesia and Analgesia 2011; 113: 843-8.
47. Shen X, Dong Y, Xu Z, et al. Selective anesthesia-induced neuroinflammation in developing mouse brain and cognitive impairment. Anesthesiology 2013; 118: 502-15.
48. Beals JK, Carter LB, Jevtovic-Todorovic V,. Neurotoxicity of nitrous oxide and ketamine is more severe in aged than in young rat brain. Annals of the New York Academy of Science 2003; 993: 115; discussion 23-4. (Pubitemid 36808439)
49. Fredriksson A, Ponten E, Gordh T, Eriksson P,. Neonatal exposure to a combination of N-methyl- d -aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology 2007; 107: 427-36. (Pubitemid 47329541)
50. Paule MG, Li M, Allen RR, et al. Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicology and Teratology 2011; 33: 220-30.
51. Dobbing J, Sands J,. Comparative aspects of the brain growth spurt. Early Human Development 1979; 3: 79-83. (Pubitemid 9141710)
52. Liu JR, Liu Q, Li J, et al. Noxious stimulation attenuates ketamine-induced neuroapoptosis in the developing rat brain. Anesthesiology 2012; 117: 64-71.
53. Anand KJ, Garg S, Rovnaghi CR, Narsinghani U, Bhutta AT, Hall RW,. Ketamine reduces the cell death following inflammatory pain in newborn rat brain. Pediatric Research 2007; 62: 283-90. (Pubitemid 47301476)
54. Fredriksson A, Archer T, Alm H, Gordh T, Eriksson P,. Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behavioural Brain Research 2004; 153: 367-76. (Pubitemid 38953110)
55. Green SM, Clark R, Hostetler MA, Cohen M, Carlson D, Rothrock SG,. Inadvertent ketamine overdose in children: clinical manifestations and outcome. Annals of Emergency Medicine 1999; 34: 492-7. (Pubitemid 29463213)
56. Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proceedings of the National Academy of Science USA 2002; 99: 15089-94. (Pubitemid 35334614)
57. Ikonomidou C, Turski L,. Antiepileptic drugs and brain development. Epilepsy Research 2010; 88: 11-22.
58. Laegreid L, Hagberg G, Lundberg A,. Neurodevelopment in late infancy after prenatal exposure to benzodiazepines-a prospective study. Neuropediatrics 1992; 23: 60-7.
59. DiMaggio C, Sun LS, Kakavouli A, Byrne MW, Li G,. A retrospective cohort study of the association of anesthesia and hernia repair surgery with behavioral and developmental disorders in young children. Journal of Neurosurgical Anesthesiology 2009; 21: 286-91.
60. De Graaff JC, Bijker JB, Kappen TH, van Wolfswinkel L, Zuithoff NP, Kalkman CJ,. Incidence of intraoperative hypoxemia in children in relation to age. Anesthesia and Analgesia 2013; 117: 169-75.
61. Marquez-Orozco MC, Gazca-Ramirez MV, de la Fuente-Juarez G, Marquez-Orozco A,. Midazolam administered to 8-day-old mouse pups for three weeks induces cerebellar cortex alterations. Proceedings of the Western Pharmacology Society 2009; 52: 109-11.
62. Holmes GL, Harden C, Liporace J, Gordon J,. Postnatal concerns in children born to women with epilepsy. Epilepsy and Behaviour 2007; 11: 270-6. (Pubitemid 350048497)
63. Bergman I, Steeves M, Burckart G, Thompson A,. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. Journal of Pediatrics 1991; 119: 644-9.
64. Hughes J, Gill A, Leach HJ, et al. A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatrica 1994; 83: 1194-9. (Pubitemid 24348092)
65. Fonsmark L, Rasmussen YH, Carl P,. Occurrence of withdrawal in critically ill sedated children. Critical Care Medicine 1999; 27: 196-9. (Pubitemid 29052837)
66. Franck LS, Naughton I, Winter I,. Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients. Intensive and Critical Care Nursing 2004; 20: 344-51. (Pubitemid 39618480)
67. Khan RB, Schmidt JE, Tamburro RF,. A reversible generalized movement disorder in critically ill children with cancer. Neurocritical Care 2005; 3: 146-9. (Pubitemid 41325112)
68. Dominguez KD, Crowley MR, Coleman DM, Katz RW, Wilkins DG, Kelly HW,. Withdrawal from lorazepam in critically ill children. Annals of Pharmacotherapy 2006; 40: 1035-9. (Pubitemid 43886959)
69. Al-Jahdari WS, Saito S, Nakano T, Goto F,. Propofol induces growth cone collapse and neurite retractions in chick explant culture. Canadian Journal of Anesthesia 2006; 53: 1078-85. (Pubitemid 44756153)
70. Honegger P, Matthieu JM,. Selective toxicity of the general anesthetic propofol for GABAergic neurons in rat brain cell cultures. Journal of Neuroscience Research 1996; 45: 631-6. (Pubitemid 26293363)
71. Yanay O, Brogan TV, Martin LD,. Continuous pentobarbital infusion in children is associated with high rates of complications. Journal of Critical Care 2004; 19: 174-8. (Pubitemid 39299184)
72. Nafiu OO, Kheterpal S, Morris M, Reynolds PI, Malviya S, Tremper KK,. Incidence and risk factors for preincision hypotension in a noncardiac pediatric surgical population. Pediatric Anesthesia 2009; 19: 232-9.
73. Tobias JD, Deshpande JK, Pietsch JB, Wheeler TJ, Gregory DF,. Pentobarbital sedation for patients in the pediatric intensive care unit. Southern Medical Journal 1995; 88: 290-4.
74. Dessens AB, Cohen-Kettenis PT, Mellenbergh GJ, Koppe JG, van De Poll NE, Boer K,. Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems. Acta Paediatrica 2000; 89: 533-41. (Pubitemid 30643411)
75. Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB,. Phenobarbital for febrile seizures-effects on intelligence and on seizure recurrence. New England Journal of Medicine 1990; 322: 364-9. (Pubitemid 20042741)
76. Gerstner T, Demirakca S, Demirakca T, et al. Relevance of phenobarbital-induced neuronal apoptosis. Psychomotor development of 8 to 14 year olds after neonatal phenobarbital treatment. Monatsschrift Kinderheilkunde 2005; 153: 1174-9.
77. Quimby KL, Aschkenase LJ, Bowman RE, Katz J, Chang LW,. Enduring learning deficits and cerebral synaptic malformation from exposure to 10 parts of halothane per million. Science 1974; 185: 625-7.
78. Stargatt R, Davidson AJ, Huang GH, et al. A cohort study of the incidence and risk factors for negative behavior changes in children after general anesthesia. Pediatric Anesthesia 2006; 16: 846-59. (Pubitemid 44086851)
79. Shih J, May LD, Gonzalez HE, et al. Delayed environmental enrichment reverses sevoflurane-induced memory impairment in rats. Anesthesiology 2012; 116: 586-602.
80. Liu D, Diorio J, Tannenbaum B, et al. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997; 277: 1659-62. (Pubitemid 27446227)
81. Uemura E, Ireland WP, Levin ED, Bowman RE,. Effects of halothane on the development of rat brain: a golgi study of dendritic growth. Experimental Neurolology 1985; 89: 503-19. (Pubitemid 15024778)
82. Uemura E, Levin ED, Bowman RE,. Effects of halothane on synaptogenesis and learning behavior in rats. Experimental Neurolology 1985; 89: 520-9. (Pubitemid 15024779)
83. Meyers EF, Muravchick S,. Anesthesia induction technics in pediatric patients: a controlled study of behavioral consequences. Anesthesia and Analgesia 1977; 56: 538-42. (Pubitemid 8159478)
84. Keaney A, Diviney D, Harte S, Lyons B,. Postoperative behavioral changes following anesthesia with sevoflurane. Pediatric Anesthesia 2004; 14: 866-70. (Pubitemid 39331510)
85. Kain ZN, Caldwell-Andrews AA, Weinberg ME, et al. Sevoflurane versus halothane: postoperative maladaptive behavioral changes: a randomized, controlled trial. Anesthesiology 2005; 102: 720-6. (Pubitemid 40462850)
86. Kotiniemi LH, Ryhanen PT,. Behavioural changes and children's memories after intravenous, inhalation and rectal induction of anaesthesia. Pediatric Anesthesia 1996; 6: 201-7. (Pubitemid 126440320)
87. Kotiniemi LH, Ryhanen PT, Moilanen IK,. Behavioural changes in children following day-case surgery: a 4-week follow-up of 551 children. Anaesthesia 1997; 52: 970-6. (Pubitemid 27455511)
88. Arnold JH, Truog RD, Rice SA,. Prolonged administration of isoflurane to pediatric patients during mechanical ventilation. Anesthesia and Analgesia 1993; 76: 520-6. (Pubitemid 23077107)
89. Kelsall AW, Ross-Russell R, Herrick MJ,. Reversible neurologic dysfunction following isoflurane sedation in pediatric intensive care. Critical Care Medicine 1994; 22: 1032-4. (Pubitemid 24182737)
90. Constant I, Seeman R, Murat I,. Sevoflurane and epileptiform EEG changes. Pediatric Anesthesia 2005; 15: 266-74. (Pubitemid 40462800)
91. Modvig KM, Nielsen SF,. Psychological changes in children after anaesthesia: a comparison between halothane and ketamine. Acta Anaesthesiologica Scandinavica 1977; 21: 541-4. (Pubitemid 8252207)
92. Zhao YL, Xiang Q, Shi QY, et al. GABAergic excitotoxicity injury of the immature hippocampal pyramidal neurons' exposure to isoflurane. Anesthesia and Analgesia 2011; 113: 1152-60.
93. Kong FJ, Ma LL, Hu WW, Wang WN, Lu HS, Chen SP,. Fetal exposure to high isoflurane concentration induces postnatal memory and learning deficits in rats. Biochemical Pharmacology 2012; 84: 558-63.
94. Kodama M, Satoh Y, Otsubo Y, et al. Neonatal desflurane exposure induces more robust neuroapoptosis than do isoflurane and sevoflurane and impairs working memory. Anesthesiology 2011; 115: 979-91.
95. Hughes J, Leach HJ, Choonara I,. Hallucinations on withdrawal of isoflurane used as sedation. Acta Paediatrica 1993; 82: 885-6. (Pubitemid 23291868)
96. Rudin M, Ben-Abraham R, Gazit V, Tendler Y, Tashlykov V, Katz Y,. Single-dose ketamine administration induces apoptosis in neonatal mouse brain. Journal of Basic and Clinical Physiology and Pharmacology 2005; 16: 231-43. (Pubitemid 43089168)
97. Kain ZN, Mayes LC, Wang SM, Hofstadter MB,. Postoperative behavioral outcomes in children: effects of sedative premedication. Anesthesiology 1999; 90: 758-65. (Pubitemid 29113696)
98. Kain ZN, Caldwell-Andrews AA, Maranets I, et al. Preoperative anxiety and emergence delirium and postoperative maladaptive behaviors. Anesthesia and Analgesia 2004; 99: 1648-54. (Pubitemid 39551897)
99. Saunders NR, Liddelow SA, Dziegielewska KM,. Barrier mechanisms in the developing brain. Frontiers in Pharmacology 2012; 3: 46.
100. Sprung J, Flick RP, Wilder RT, et al. Anesthesia for cesarean delivery and learning disabilities in a population-based birth cohort. Anesthesiology 2009; 111: 302-10.
101. Wilder RT, Flick RP, Sprung J, et al. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 2009; 110: 796-804.
102. Ing C, DiMaggio C, Whitehouse A, et al. Long-term differences in language and cognitive function after childhood exposure to anesthesia. Pediatrics 2012; 130: e476-85.
103. Hansen TG, Pedersen JK, Henneberg SW, et al. Academic performance in adolescence after inguinal hernia repair in infancy: a nationwide cohort study. Anesthesiology 2011; 114: 883-90.
104. Bartels M, Althoff RR, Boomsma DI,. Anesthesia and cognitive performance in children: no evidence for a causal relationship. Twin Research and Human Genetics 2009; 12: 246-53.
105. Hansen TG, Pedersen JK, Henneberg SW, Morton NS, Christensen K,. Educational outcome in adolescence following pyloric stenosis repair before 3 months of age: a nationwide cohort study. Pediatric Anesthesia 2013; 23: 883-90.
106. Hansen TG, Henneberg SW, Morton NS, et al. Pro-con debate: cohort studies vs the randomized clinical trial methodology in pediatric anesthesia. Pediatric Anesthesia 2010; 20: 880-94.
107. Istaphanous KG, Howard J, Nan X, et al. Comparison of the neuroapoptotic properties of equipotent anesthetic concentrations of desflurane, isoflurane, or sevoflurane in neonatal mice. Anesthesiology 2011; 114: 578-87.
108. Flick RP, Katusic SK, Colligan RC, et al. Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics 2011; 128: e1053-61.
109. Crawford MW, Lerman J, Saldivia V, Carmichael FJ,. Hemodynamic and organ blood flow responses to halothane and sevoflurane anesthesia during spontaneous ventilation. Anesthesia and Analgesia 1992; 75: 1000-6.
110. Weiss M, Bissonnette B, Engelhardt T, Soriano S,. Anesthetists rather than anesthetics are the threat to baby brains. Pediatric Anesthesia 2013; 23: 881-2.
111. Taddio A, Katz J, Ilersich AL, Koren G,. Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet 1997; 349: 599-603. (Pubitemid 27101886)
112. Anand KJ, Coskun V, Thrivikraman KV, Nemeroff CB, Plotsky PM,. Long-term behavioral effects of repetitive pain in neonatal rat pups. Physiology and Behaviour 1999; 66: 627-37. (Pubitemid 29251270)
113. Ruda MA, Ling QD, Hohmann AG, Peng YB, Tachibana T,. Altered nociceptive neuronal circuits after neonatal peripheral inflammation. Science 2000; 289: 628-31.
114. Yon JH, Carter LB, Reiter RJ, Jevtovic-Todorovic V,. Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiology of Disease 2006; 21: 522-30. (Pubitemid 43277535)
115. Straiko MM, Young C, Cattano D, et al. Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology 2009; 110: 862-8.
116. Sanders RD, Xu J, Shu Y, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology 2009; 110: 1077-85.
117. Bertolizio G, Mason L, Bissonnette B,. Brain temperature: heat production, elimination and clinical relevance. Pediatric Anesthesia 2011; 21: 347-58.
118. Steven J, Nicolson S,. Perioperative management of blood glucose during open heart surgery in infants and children. Pediatric Anesthesia 2011; 21: 530-7.
119. Available at: www.smarttots.org (accessed 07/02/2014).
120. Available at: www.euroanaesthesia.org/sitecore/Content/About-the-ESA/ESA- Committees/Research%20Committee/EuroSTAR.aspx (accessed 07/02/2014).
121. Becke K, Schreiber M, Philippi-Hohne C, Strauss J, Engelhard K, Sinzuhner B,. Anesthesia-induced neurotoxicity: statement of the scientific working groups for pediatric anesthesia and neuroanesthesia. Anaesthesist 2013; 62: 101-4.